| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/10/2004 | CA2515129A1 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues |
| 09/10/2004 | CA2514781A1 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor |
| 09/10/2004 | CA2513836A1 Hypoallergenic der p1 and der p3 proteins from dermatographoides pteronyssinus |
| 09/10/2004 | CA2513742A1 Enhanced expression of fusion polypeptides with a biotinylation tag |
| 09/09/2004 | US20040177405 including drought and high salt concentration by increasing galactinol content; genetic engineering |
| 09/09/2004 | US20040177404 Nucleotide sequences of 2S albumin gene and its promoter from grape and uses thereof |
| 09/09/2004 | US20040177403 Genes encoding protein participating in cytokinin synthesis |
| 09/09/2004 | US20040177402 Genetic engineering of plant chloroplasts |
| 09/09/2004 | US20040177401 Genes encoding sulfate assimilation proteins |
| 09/09/2004 | US20040177400 Methods and constructs for increasing the content of selected amino acids in seeds |
| 09/09/2004 | US20040177399 Genes conferring herbicide resistance |
| 09/09/2004 | US20040177397 Prenatal screening |
| 09/09/2004 | US20040177396 Genetically engineered cleft palate rodent model comprising vector coding fluorescent reporter wherein gamma -aminobutyric acid neurons can be visualized in vivo; tissue engineering and diagnostic analysis |
| 09/09/2004 | US20040177393 Genetically engineered rodent which expresses glycoprotein 120 binding ligand for diagnosis, prevention, detection and treatment of lentiviral infection; viricides |
| 09/09/2004 | US20040177392 Crustaceans as production systems for therapeutic proteins |
| 09/09/2004 | US20040177391 Cell signaling associated polypeptides for identifying modulators of immune cell interactions and mamalian cellular response; tissue engineering |
| 09/09/2004 | US20040177390 Method of nuclear transfer |
| 09/09/2004 | US20040177388 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 09/09/2004 | US20040176716 Electrode apparatus and method for the delivery of drugs and genes into tissue |
| 09/09/2004 | US20040176586 Process for detecting the presence or quantity of enzymatic activity in a sample |
| 09/09/2004 | US20040176583 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 09/09/2004 | US20040176582 Expression vector comprising osteocalcin promoter and nucleotide sequence coding bone morphogenic protein for treatment and prevention of osteoporosis |
| 09/09/2004 | US20040176574 Comprises organic cation transporter polypeptide for use in diagnostic, prevention and treatment of metabolic and cell proliferative disorders |
| 09/09/2004 | US20040176571 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 09/09/2004 | US20040176570 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 09/09/2004 | US20040176568 Nucleic acids encoding modified parathyroid hormone |
| 09/09/2004 | US20040176567 Bioactive peptides comprising enhanced solubility and reduced aggregatory characteristics for use in diagnosis, prevention and treatment of hypercalaemia, osteoporosis and paget's disease |
| 09/09/2004 | US20040176473 Methods for delivering compounds into a cell |
| 09/09/2004 | US20040176298 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| 09/09/2004 | US20040176286 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/09/2004 | US20040176285 Tip39 polypeptides |
| 09/09/2004 | US20040176282 Cellular delivery and activation of polypeptide-nucleic acid complexes |
| 09/09/2004 | US20040176279 Flint glycoforms |
| 09/09/2004 | US20040176278 B-superfamily conotoxins |
| 09/09/2004 | US20040176275 Pharmaceutical composition for alleviating tissue hypoxia and methods for alleviating tissue hypoxia |
| 09/09/2004 | US20040175831 Strains "fil", stress-resistant under fermentation and/or growth conditions |
| 09/09/2004 | US20040175830 Phagemid vectors |
| 09/09/2004 | US20040175829 Nucleocapsid-independent specific viral RNA packaging and uses thereof |
| 09/09/2004 | US20040175825 for drug screening/diagnostics for inflammation, arthritis and cancer; genetic engineering; kits |
| 09/09/2004 | US20040175815 kit for treating chronic obstructive pulmonary disease, cancer, and diseases in which cell signaling is defective |
| 09/09/2004 | US20040175807 Beta1, 3-galactose transferase and dna encoding the enzyme |
| 09/09/2004 | US20040175805 Method for fermentative preparation of S-adenosylmethionine |
| 09/09/2004 | US20040175803 Interferon-alpha induced gene |
| 09/09/2004 | US20040175800 for genetically engineered proteins with increase in solubility and in vivo stability and a decrease in immunogenicity |
| 09/09/2004 | US20040175798 Expression system for recombinant proteins |
| 09/09/2004 | US20040175791 DcR3 polypeptide, a TNFR homolog |
| 09/09/2004 | US20040175789 for drug screening asthma, chronic obstructive pulmonary disease, emphysema, chronic bronchitis, acute respiratory distress syndrome, cough and acute bronchitis drugs; genetic engineering |
| 09/09/2004 | US20040175787 for treating spastcity, trigeminal neuralgia, asthma, cough, emesis, ulcers, urinary incontinence and cocaine addiction |
| 09/09/2004 | US20040175786 for the prevention of acute rejection reactions following organ transplantation; genetic engineering |
| 09/09/2004 | US20040175778 Method for increasing productivity of secondary metabolite by conferring drug-resistant mutations |
| 09/09/2004 | US20040175773 Screening method based on siah-numb interaction |
| 09/09/2004 | US20040175766 Human pyrimidine receptor |
| 09/09/2004 | US20040175757 Low allergenic protein variants |
| 09/09/2004 | US20040175748 Using alterations in cyclin dependent kinase activity to identify modulators which inhibit or potentiate cellular senescence; antiaging/anticancer agents; enzyme inhibitors |
| 09/09/2004 | US20040175740 Using proopiomelanocortin animal mutant to identify modulators of weight and pancreatic disorders |
| 09/09/2004 | US20040175736 Using nested oligonucleotide extension reaction to replicate preferential nucleotide sequences; gene expression analysis |
| 09/09/2004 | US20040175735 Using nucleic acid immobilized solid phase and temperature variation to isolate both RNA and DNA present in eluate; nucleotide sequence purification |
| 09/09/2004 | US20040175734 Support for analyte determination methods and method for producing the support |
| 09/09/2004 | US20040175731 Preparing transgenic microorganism comprising modified intercellular adhesion (ica) locus and which generates cell surface proteins with altered poly-N-acetyl glucosamine (PNAG) side chain profile for use in vaccine development; bactericides |
| 09/09/2004 | US20040175730 Comprises nucleotide sequences coding polypeptide associated with vascular permeability or proliferation of endothelial cells for treating intestinal malabsorption syndrome |
| 09/09/2004 | US20040175729 Primer for nucleic acid amplification to detect carcinoembryonic antigen and test method using such primer |
| 09/09/2004 | US20040175727 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells |
| 09/09/2004 | US20040175725 Drosophila clipped FRT (cFRT) chromosome insensitive to P transposase, generating method thereof, and application thereof |
| 09/09/2004 | US20040175723 using oligonucleotide primers that hybridise to the genes encoding shiga-like toxin; for high throughput assays |
| 09/09/2004 | US20040175722 Identifying cell comprising preferential nucleic acid mutation using sited diredted mutagenesis and reducing the number of target nucleic acid |
| 09/09/2004 | US20040175719 Nucleotide sequences probes comprised of 20-60 bases for use as diagnostic tools and controls in genic analysis; bioassay |
| 09/09/2004 | US20040175716 Dna sequence analysis |
| 09/09/2004 | US20040175714 Human protooncogene kg-20 and protein encoded therein |
| 09/09/2004 | US20040175712 Method for the identification of activators of g protein-coupled receptors and nucleic acids encoding those receptors |
| 09/09/2004 | US20040175711 using genetically engineered vector and trichoderma host; can be obtained independently of the saponin content of a soybean extract |
| 09/09/2004 | US20040175709 Analytical method and kit |
| 09/09/2004 | US20040175706 Nucleotide sequences comprising mutation associated with arthritic disorders; allelic variation, disease and gene therapy |
| 09/09/2004 | US20040175705 Expression vector for transformation and expression of heterologous polypeptides in methylococcal/methanotrophic bacteria; bioreactors |
| 09/09/2004 | US20040175703 to be administered by inhalation, infusion, injection, or orally relates to double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference in vitro and in vivo; genetic engineering |
| 09/09/2004 | US20040175699 Nucleotide sequences coding myosin binding protein-C 3-cardiac (MYBPC) regulatory sequence for use as gene therapeutic tools in expressing proteins for treating cardiomyopathies, myocardial infarction and cardiac rhythm disorders |
| 09/09/2004 | US20040175698 Regulation of human latrophilin-like g protein-coupled receptor |
| 09/09/2004 | US20040175697 Methods of isolating rna-binding proteins and compositions related to the same |
| 09/09/2004 | US20040175694 Tobamovirus vector for transformation and propagation of protective antibodies in plants; genetic vaccine for preventing parasitic infections |
| 09/09/2004 | US20040175441 plant-derived recombinant amino acid sequence in the manufacture of a medicament for the prevention or treatment of disease in fish |
| 09/09/2004 | US20040175440 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 09/09/2004 | US20040175395 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; diagnostic kits for respiratory syncytial virus |
| 09/09/2004 | US20040175393 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and imunological therapies based thereon |
| 09/09/2004 | US20040175380 Compositions and methods for modulating lymphocyte activity |
| 09/09/2004 | US20040175376 Of ascomycetes and/or basidiomycetes and corresponding cloned DNA sequences; heat resistance |
| 09/09/2004 | US20040175375 Downregulation of c-myc by promoting the ubiquitination of FBP, by administering an isolated p38/JTV-1protein or fragment or an isolated nucleic acid encoding said protein; |
| 09/09/2004 | US20040175372 Inhibits rotavirus infection and other pathogenic microorganisms; viricides; preventing and treating diarrhea of mammals, livestock, and poultry |
| 09/09/2004 | US20040175365 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 09/09/2004 | US20040175364 Gene transfer with adenoviruses having modified fiber proteins |
| 09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
| 09/09/2004 | US20040175362 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 09/09/2004 | US20040175357 IL-2 selective agonists and antagonists |
| 09/09/2004 | US20040175356 Cysteine variants of interleukin-11 |
| 09/09/2004 | DE10308850A1 Preparation of conjugated polyunsaturated fatty acids, useful in nutrition, cosmetics and pharmaceuticals, comprises expressing specific isomerases in eukaryotic, particularly plant, cells |
| 09/09/2004 | DE10226702A1 Antisense Oligonukleotide gegen PIM1 Antisense oligonucleotides against PIM1 |
| 09/09/2004 | DE10212893A9 Verfahren zum Erhöhen des Ölgehaltes in Pflanzen A method for increasing the oil content in plants |
| 09/09/2004 | DE10212892A9 Konstrukte und Verfahren zur Regulation der Genexpression Constructs and methods for regulation of gene expression |
| 09/08/2004 | EP1455190A1 Modulation of the activity of nuclear receptors via EWS |
| 09/08/2004 | EP1455186A1 Screening method |
| 09/08/2004 | EP1454991A1 Coryneform bacterium transformed to utilize methanol as carbon source |
| 09/08/2004 | EP1454988A1 Infectious flavivirus pseudo-particles containing functional prM-E envelope proteins |